Infectious Diseases (except HIV/AIDS)

  1. Analysis of SARS-CoV-2 variants from 24,181 patients exemplifies the role of globalisation and zoonosis in pandemics

    1. Philippe Colson
    2. Pierre-Edouard Fournier
    3. Hervé Chaudet
    4. Jérémy Delerce
    5. Audrey Giraud-Gatineau
    6. Linda Houhamdi
    7. Claudia Andrieu
    8. Ludivine Brechard
    9. Marielle Bedotto
    10. Elsa Prudent
    11. Céline Gazin
    12. Mamadou Beye
    13. Emilie Burel
    14. Pierre Dudouet
    15. Hervé Tissot-Dupont
    16. Philippe Gautret
    17. Jean-Christophe Lagier
    18. Matthieu Million
    19. Philippe Brouqui
    20. Philippe Parola
    21. Michel Drancourt
    22. Bernard La Scola
    23. Anthony Levasseur
    24. Didier Raoult

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost

    1. Amar K. Garg
    2. Soumya Mittal
    3. Pranesh Padmanabhan
    4. Rajat Desikan
    5. Narendra M. Dixit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Elevated plasma levels of CXCL16 in severe COVID-19 patients

    1. Sandra P. Smieszek
    2. Vasilios M. Polymeropoulos
    3. Christos M. Polymeropoulos
    4. Bartlomiej P. Przychodzen
    5. Gunther Birznieks
    6. Mihael H. Polymeropoulos

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

    1. Gwenan M. Knight
    2. Thi Mui Pham
    3. James Stimson
    4. Sebastian Funk
    5. Yalda Jafari
    6. Diane Pople
    7. Stephanie Evans
    8. Mo Yin
    9. Colin S. Brown
    10. Alex Bhattacharya
    11. Russell Hope
    12. Malcolm G. Semple
    13. ISARIC4C Investigators
    14. CMMID COVID-19 Working Group
    15. Sam Abbott
    16. Amy Gimma
    17. Hamish P. Gibbs
    18. Kaja Abbas
    19. Rosanna C. Barnard
    20. Frank G. Sandmann
    21. Nikos I. Bosse
    22. Paul Mee
    23. Ciara V. McCarthy
    24. Matthew Quaife
    25. Adam J. Kucharski
    26. Christopher I. Jarvis
    27. Joel Hellewell
    28. Emilie Finch
    29. Alicia Rosello
    30. Mark Jit
    31. Rachael Pung
    32. Rosalind M. Eggo
    33. Akira Endo
    34. Graham Medley
    35. Damien C. Tully
    36. Kerry L. M. Wong
    37. Yang Liu
    38. Katharine Sherratt
    39. James D. Munday
    40. Lloyd A. C. Chapman
    41. Stéphane Hué
    42. Kathleen O’Reilly
    43. Nicholas G. Davies
    44. Sophie R. Meakin
    45. Fiona Yueqian Sun
    46. Oliver Brady
    47. C. Julian Villabona-Arenas
    48. Katherine E. Atkins
    49. Kiesha Prem
    50. David Hodgson
    51. Mihaly Koltai
    52. Carl A. B. Pearson
    53. William Waites
    54. Simon R. Procter
    55. Rachel Lowe
    56. Jonathan M. Read
    57. Ben S. Cooper
    58. Julie V. Robotham

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers

    1. Gemma Moncunill
    2. Ruth Aguilar
    3. Marta Ribes
    4. Natalia Ortega
    5. Rocío Rubio
    6. Gemma Salmerón
    7. María José Molina
    8. Marta Vidal
    9. Diana Barrios
    10. Robert A. Mitchell
    11. Alfons Jiménez
    12. Cristina Castellana
    13. Pablo Hernández-Luis
    14. Pau Rodó
    15. Susana Méndez
    16. Anna Llupià
    17. Laura Puyol
    18. Natalia Rodrigo Melero
    19. Carlo Carolis
    20. Alfredo Mayor
    21. Luis Izquierdo
    22. Pilar Varela
    23. Antoni Trilla
    24. Anna Vilella
    25. Sonia Barroso
    26. Ana Angulo
    27. Pablo Engel
    28. Marta Tortajada
    29. Alberto L. García-Basteiro
    30. Carlota Dobaño

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

    1. Jennifer M. Polinski
    2. Andrew R. Weckstein
    3. Michael Batech
    4. Carly Kabelac
    5. Tripthi Kamath
    6. Raymond Harvey
    7. Sid Jain
    8. Jeremy A. Rassen
    9. Najat Khan
    10. Sebastian Schneeweiss

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

    1. Mark A Brockman
    2. Francis Mwimanzi
    3. Hope R Lapointe
    4. Yurou Sang
    5. Olga Agafitei
    6. Peter K Cheung
    7. Siobhan Ennis
    8. Kurtis Ng
    9. Simran Basra
    10. Li Yi Lim
    11. Fatima Yaseen
    12. Landon Young
    13. Gisele Umviligihozo
    14. F Harrison Omondi
    15. Rebecca Kalikawe
    16. Laura Burns
    17. Chanson J Brumme
    18. Victor Leung
    19. Julio S G Montaner
    20. Daniel Holmes
    21. Mari L DeMarco
    22. Janet Simons
    23. Ralph Pantophlet
    24. Masahiro Niikura
    25. Marc G Romney
    26. Zabrina L Brumme

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Comprehensive evaluation of COVID-19 patient short- and long-term outcomes: Disparities in healthcare utilization and post-hospitalization outcomes

    1. Stephen Salerno
    2. Yuming Sun
    3. Emily L. Morris
    4. Xinwei He
    5. Yajing Li
    6. Ziyang Pan
    7. Peisong Han
    8. Jian Kang
    9. Michael W. Sjoding
    10. Yi Li

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A randomized controlled trial of inhaled ciclesonide for outpatient treatment of symptomatic COVID-19 infections

    1. Brian M. Clemency
    2. Renoj Varughese
    3. Yaneicy Gonzalez-Rojas
    4. Caryn G. Morse
    5. Wanda Phipatanakul
    6. David J. Koster
    7. Michael S. Blaiss

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

    1. Peter Bergman
    2. Ola Blennow
    3. Lotta Hansson
    4. Stephan Mielke
    5. Piotr Nowak
    6. Puran Chen
    7. Gunnar Söderdahl
    8. Anders Österborg
    9. C. I. Edvard Smith
    10. David Wullimann
    11. Jan Vesterbacka
    12. Gustaf Lindgren
    13. Lisa Blixt
    14. Gustav Friman
    15. Emilie Wahren-Borgström
    16. Anna Nordlander
    17. Angelica Cuapio Gomez
    18. Mira Akber
    19. Davide Valentini
    20. Anna-Carin Norlin
    21. Anders Thalme
    22. Gordana Bogdanovic
    23. Sandra Muschiol
    24. Peter Nilsson
    25. Sophia Hober
    26. Karin Loré
    27. Margaret Sällberg Chen
    28. Marcus Buggert
    29. Hans-Gustaf Ljunggren
    30. Per Ljungman
    31. Soo Aleman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 302 of 716 Next